Facts Matter (Nov. 5): Whistleblower Exposes Data Integrity Issues in Pfizer’s Clinical Trial

According to its newly published earnings report, Pfizer is proverbially swimming in cash. In fact, both its revenue, as well as its profits, have more than doubled in the third quarter of this year, when you compare it to a year ago. And most of that growth, as you can guess, is being driven by vaccine sales. That number migh...